CSIR Central

Antidiabetic plant-derived nutraceuticals: a critical review.

IR@CFTRI: CSIR-Central Food Technological Research Institute, Mysore

View Archive Info
 
 
Field Value
 
Relation http://ir.cftri.com/13558/
https://dx.doi.org/10.1007/s00394-017-1552-6
 
Title Antidiabetic plant-derived nutraceuticals: a critical review.
 
Creator Naveen, J.
Baskaran, V.
 
Subject 10 Plants
04 Diabetes Mellitus
 
Description Diabetes mellitus (DM) is one of the major health problems in the world, especially amongst the urban population. Chemically synthesized drugs used to decrease the ill effects of DM and its secondary complications cause adverse side effects, viz., weight gain, gastrointestinal disturbances, and heart failure. Currently, various other approaches, viz., diet control, physical exercise and use of antidiabetic plant-derived molecules/foods are advocated to manage DM, as they are economical with fewer or no side effects. This review mainly focuses on antidiabetic plants, chemically characterized plant molecules and plant-based foods in the treatment of DM. Very little science-based evidence is available on the mechanism of action of plantderived food molecules on the DM targets. Critical DM targets include α-amylase, α-glucosidase, DPP-IV, aldose reductase, PPAR-γ, AMP kinase and GLUT4. In-depth studies carried out on a few of those targets with specific mechanisms of action are addressed in this review. This review may help future researchers in identifying a right plant molecule to treat DM or to develop food formulations for DM management.
 
Date 2018
 
Type Article
PeerReviewed
 
Format pdf
 
Language en
 
Identifier http://ir.cftri.com/13558/1/Eur%20J%20Nutr%202017.pdf
Naveen, J. and Baskaran, V. (2018) Antidiabetic plant-derived nutraceuticals: a critical review. European Journal of Nutrition, 57 (4). pp. 1275-1299.